Jnba Financial Advisors Boston Scientific Corp Transaction History

Jnba Financial Advisors

  • $951 Million
  • Q1 2024

A detailed history of Jnba Financial Advisors transactions in Boston Scientific Corp stock. As of the latest transaction made, Jnba Financial Advisors holds 6,863 shares of BSX stock, worth $525,362. This represents 0.05% of its overall portfolio holdings.

Number of Shares
6,863
Previous 6,925 0.9%
Holding current value
$525,362
Previous $400,000 17.5%
% of portfolio
0.05%
Previous 0.05%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 26, 2024
SELL
$57.6 - $68.62 $3,571 - $4,254
-62 Reduced 0.9%
6,863 $470,000
Q4 2023

Feb 07, 2024
SELL
$48.64 - $57.81 $3,112 - $3,699
-64 Reduced 0.92%
6,925 $400,000
Q3 2023

Nov 02, 2023
BUY
$50.19 - $54.68 $3,212 - $3,499
64 Added 0.92%
6,989 $369,000
Q1 2023

May 01, 2023
BUY
$45.09 - $50.03 $2,795 - $3,101
62 Added 0.9%
6,925 $346,000
Q4 2022

Feb 06, 2023
SELL
$39.56 - $47.22 $36,434 - $43,489
-921 Reduced 11.83%
6,863 $317,000
Q2 2021

Aug 04, 2021
BUY
$38.58 - $44.24 $25,887 - $29,685
671 Added 9.43%
7,784 $333,000
Q1 2021

May 03, 2021
BUY
$35.27 - $39.67 $8,817 - $9,917
250 Added 3.64%
7,113 $275,000
Q2 2020

Jul 24, 2020
SELL
$30.19 - $39.11 $13,132 - $17,012
-435 Reduced 5.96%
6,863 $241,000
Q3 2019

Nov 01, 2019
SELL
$40.31 - $43.45 $4,031 - $4,345
-100 Reduced 1.35%
7,298 $297,000
Q2 2019

Jul 26, 2019
BUY
$34.91 - $42.98 $3,490 - $4,298
100 Added 1.37%
7,398 $318,000
Q4 2018

Feb 07, 2019
BUY
$31.73 - $39.04 $231,565 - $284,913
7,298 New
7,298 $258,000
Q3 2018

Nov 01, 2018
SELL
$32.83 - $38.63 $239,593 - $281,921
-7,298 Closed
0 $0
Q2 2017

Aug 14, 2017
BUY
N/A
7,298
7,298 $202,000

Others Institutions Holding BSX

# of Institutions
1,321
Shares Held
1.17B
Call Options Held
5.92M
Put Options Held
5.75M
View Full List

About BOSTON SCIENTIFIC CORP

BSX Quotes by TradingView
  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $110B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Jnba Financial Advisors Portfolio

Follow Jnba Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jnba Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Jnba Financial Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email